The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB
肝癌患者使用免疫检查点抑制剂的安全问题主要源于慢性乙型肝炎。
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1164309
Lou, Shike; Cao, Zhujun; Chi, Wanqing; Wang, Xiaoyin; Feng, Mingyang; Lin, Lanyi; Ding, Yezhou; Liu, Kehui; Qu, Lihong; Zhao, Gangde; Bao, Shisan; Wang, Hui